These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2543511)

  • 1. Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.
    Chetiyawardana SD; Cullen MH; Joshi RC; Woodroffe CM
    Cancer Chemother Pharmacol; 1989; 24(2):102-4. PubMed ID: 2543511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
    Currie DC; Miles DW; Drake JS; Rudd R; Spiro SG; Earl HM; Harper PG; Tobias JS; Souhami RL
    Cancer Chemother Pharmacol; 1990; 25(5):380-1. PubMed ID: 2155066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
    Cullen MH
    Oncology; 1993 Apr; 50 Suppl 1():31-4. PubMed ID: 8387176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
    Cullen MH; Joshi R; Chetiyawardana AD; Woodroffe CM
    Br J Cancer; 1988 Sep; 58(3):359-61. PubMed ID: 2846024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Rosell R; Abad-Esteve A; Moreno I; Barnadas A; Carles J; Fernandez C; Ribelles N; Culubret M
    Cancer; 1990 Apr; 65(8):1692-9. PubMed ID: 2156597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Girón CG; Ordónez A; Jalón JI; Barón MG
    Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
    Furuse K; Kubota K; Kawahara M; Kodama N; Ogawara M; Akira M; Nakajima S; Takada M; Kusunoki Y; Negoro S
    J Clin Oncol; 1995 Apr; 13(4):869-75. PubMed ID: 7707113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
    Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer.
    Urban T; Bedin A; Baud M; Chouaid C; Febvre M; Lebeau B
    Lung Cancer; 1996 Feb; 14(1):109-17. PubMed ID: 8696714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
    Ellis PA; Smith IE; Hardy JR; Nicolson MC; Talbot DC; Ashley SE; Priest K
    Br J Cancer; 1995 Feb; 71(2):366-70. PubMed ID: 7530988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).
    Han JY; Kim HK; Choi BG; Moon H; Hong YS; Lee KS
    Jpn J Clin Oncol; 1998 Dec; 28(12):749-53. PubMed ID: 9879293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancer.
    von Rohr A; Anderson H; McIntosh R; Thatcher N
    Eur J Cancer; 1991; 27(9):1106-8. PubMed ID: 1659850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
    Miller VA; Rigas JR; Pisters KM; Grant SC; Pfister DG; Heelan RT; Kris MG
    Am J Clin Oncol; 1995 Aug; 18(4):303-6. PubMed ID: 7625371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
    Graziano SL; Herndon JE; Richards F; DiFino S; Modeas C; Duggan DB; Green MR
    Cancer; 1993 Jul; 72(1):62-8. PubMed ID: 8389667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
    Mirimanoff RO; Moro D; Bolla M; Michel G; Brambilla C; Mermillod B; Miralbell R; Alberto P
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):487-94. PubMed ID: 9806505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Shepherd FA; Evans WK; Goss PE; Latreille J; Logan D; Maroun J; Stewart D; Warner E; Paul K
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):54-8. PubMed ID: 1329213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.
    Gomm SA; Thatcher N; Cuthbert A; Chang J; Burmester H; Hall P; Carroll KB
    Br J Cancer; 1991 Feb; 63(2):293-7. PubMed ID: 1847648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.